Reducing Risk of Infection: BlueWillow Biologics to Launch NanoBio® Protect OTC Nasal Antiseptic Solution

BlueWillow Biologics®, a clinical-stage biopharmaceutical company, today announced the company will advance the manufacturing and commercialization of NanoBio® Protect, a nasal antiseptic solution that can be used to help reduce germs that could cause infections. NanoBio® Protect will be available for purchase over-the-counter by hospitals, businesses and consumers.  NanoBio® Protect is an alcohol-free, nasal antiseptic … Continued

Delphinus Study Finds Potential of Whole Breast Ultrasound Tomography to Improve Breast Cancer Risk Assessment

Delphinus Medical Technologies, Inc., the leader in advanced breast ultrasound technology, has announced that results of a study comparing the use of whole breast ultrasound tomography (UST) and mammography to assess breast cancer risk have been published in the Journal of Clinical Medicine. The study was conducted by researchers at the National Cancer Institute, the … Continued

Larky Joins Visa’s Fintech Fast Track Program

Larky today announced that it has joined Visa’s Fintech Fast Track program, speeding up the process of integrating Larky’s nudge® engagement platform with the VisaNet global payment network. Through Fast Track, Larky is now able to drive card use through their geo-targeted engagement platform in mobile banking apps. The Larky nudge® engagement platform enables financial institutions … Continued

Access Softek and Larky Announce Reseller Partnership

Today, fintech and geo-location marketing leader Larky announced a reseller partnership to bundle the nudge® geo-location and engagement technology into Access Softek’s cutting-edge mobile banking app. Digital banking developer, Access Softek will deploy their right place/right time technology to their financial institution clients. The innovative nudge® code library empowers financial institutions to connect with their … Continued

Blue Medora Builds Strong Momentum Into 2020

Blue Medora, the leading provider of enterprise IT monitoring integration solutions, reported today that it closed a record-breaking year in 2019 with sector-leading performances across revenue, customer acquisition and product innovation as well as adding key hires to its executive staff. The leading indicator of the company’s growth is its thriving customer acquisition. Blue Medora’s … Continued

High School Sports Platform VNN Acquires Fundraising App RallyAroundUs

High school sports communications platform VNN has announced its acquisition of fundraising app RallyAroundUs. The crowdsourcing app will now be integrated into VNN’s SportsHub communications platform, which is used by 10% of all high school athletic departments in the U.S. Athletes and teams can film and upload videos to drive fundraising efforts inside the RallyAroundUs mobile … Continued

BlueWillow Receives FDA Clearance to Begin Phase 1 Study of its Intranasal Anthrax Vaccine

BlueWillow Biologics®, a clinical-stage biopharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for BW-1010, the company’s next-generation anthrax vaccine candidate. The Phase 1 clinical study is expected to begin enrollment this year and is being funded by the National Institute of Allergy and Infectious … Continued

The American Academy of Physical Medicine and Rehabilitation Selects ArborMetrix As Its Technology and Analytics Partner

The American Academy of Physical Medicine and Rehabilitation (AAPM&R) has selected ArborMetrix as its partner for a new, state-of-the-art physiatry clinical data registry. The registry will advance AAPM&R’s ability to collect high-quality, clinician and patient data across independent physician practices and larger institutions for use in generating insights to inform best practices, guide pioneering research, and … Continued

Blue Medora Appoints Bekim Protopapa CEO

Blue Medora, the leading provider of enterprise IT monitoring integration solutions, announced today that the Company’s Board of Directors has appointed Bekim Protopapa as President and Chief Executive Officer. He will assume day-to-day leadership of the Company and will also join Blue Medora’s Board of Directors. Bekim is a highly experienced senior executive, having spent … Continued

BlueWillow Awarded NIH Contract to Advance Development of its Therapeutic Peanut Allergy Vaccine

BlueWillow Biologics®, a clinical-stage biopharmaceutical company, today announced it has been awarded a Fast-Track Small Business Research Innovation (SBIR) contract from the National Institute of Allergy and Infectious Diseases (NIAID) for the development of an intranasal therapeutic peanut allergy vaccine using the company’s NanoVax® platform. Pending approval of all phases, the contract will provide funding … Continued